Ge, Liu et al. develop and validate a survival model (SM-CRT) using multicentre data from 30,947 cancer patients to predict catheter-related thrombosis (CRT) risk. The model accurately identifies high-risk patients and high-risk time periods, supporting personalised thromboprophylaxis and optimised catheter removal timing.
